News
ONE HEMP – a coalition of industry leaders committed to advancing regulatory standards for hemp-derived cannabinoid (CBD) products – issued a statement of strong support for Governor Greg Abbott's ...
Below are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal antibody that binds to and inhibits activin receptor type-2B, with semaglutide ...
More than 50 insurers have pledged to streamline and simplify the prior authorization process through six new commitments.
Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss ...
This new pill works by triggering the metabolism in the muscles, activating them to burn more fat, without the ...
Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the US company is ...
A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
A PILL to make you buff is a step nearer to reality as inventors move onto the next phase of human trials. Scientists say the ...
Prescriptions for Mounjaro jabs, to help people lose weight, will be available at GP surgeries in England from today - but ...
Participants in the 72-week STEP UP trial who received the increased Wegovy dose of 7.2 mg experienced a mean weight reduction of 21%, while a third of them reached 25% body weight loss. Adults with ...
A new obesity drug combining four hormones may outperform Wegovy and Mounjaro. Learn what it means for health, science, and investors.
ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the first patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results